http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021534178-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4152
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
filingDate 2019-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2021534178-A
titleOfInvention Substituted pyrazole compounds, preparation methods thereof, pharmaceutical compositions and uses
abstract The present invention is to obtain substituted pyrazole compounds, methods for preparing them, pharmaceutical compositions and uses. The compound has good stability, excellent solubility, low toxicity to cells, remarkable protective effect on nerves, effective prevention and treatment of nerve cell damage, and stroke. It is an ideal pharmaceutical compound for the prevention or treatment of cerebral embolism, sequelae of stroke, stroke motor dysfunction, mitochondrial encephalomyopathy, and muscular atrophic lateral sclerosis. [Chemical 1]
priorityDate 2018-08-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465132536
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID146422836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410106143
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID146422837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408413016
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465501374
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163463512
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465017512
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID146422878
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID146422850

Total number of triples: 37.